|
Volumn 3, Issue 5, 2002, Pages 499-504
|
The prevention of sudden death in hypertrophic cardiomyopathy
|
Author keywords
Heart disease; Hypertrophic cardiomyopathy; Sudden death
|
Indexed keywords
AMIODARONE;
ANTIARRHYTHMIC AGENT;
MUSCLE PROTEIN;
CARDIOVASCULAR RISK;
COMPLICATION;
CONTROLLED STUDY;
DEFIBRILLATOR;
DIAGNOSTIC PROCEDURE;
DISEASE PREDISPOSITION;
DOSE RESPONSE;
FAMILIAL DISEASE;
GENE MUTATION;
HEART DEATH;
HEART MUSCLE;
HEART MUSCLE FIBROSIS;
HIGH RISK PATIENT;
HUMAN;
HUMAN TISSUE;
HYPERTROPHIC CARDIOMYOPATHY;
MORTALITY;
MUSCLE CELL;
MYOCARDIAL DISEASE;
PREVALENCE;
REVIEW;
RISK ASSESSMENT;
SARCOMERE;
SUDDEN DEATH;
SYMPTOMATOLOGY;
TREATMENT INDICATION;
ADULT;
ALGORITHMS;
CARDIOMYOPATHY, HYPERTROPHIC;
DEATH, SUDDEN, CARDIAC;
EXPERT TESTIMONY;
HUMANS;
RISK FACTORS;
|
EID: 0036096945
PISSN: 14656566
EISSN: None
Source Type: Journal
DOI: 10.1517/14656566.3.5.499 Document Type: Review |
Times cited : (6)
|
References (44)
|